Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

LF3

🥰Excellent
Catalog No. T7399Cas No. 664969-54-4

LF3 is a specific inhibitor of canonical Wnt signaling by disrupting the interaction between β-catenin and TCF4 (IC50 < 2 μM)

LF3

LF3

🥰Excellent
Catalog No. T7399Cas No. 664969-54-4
LF3 is a specific inhibitor of canonical Wnt signaling by disrupting the interaction between β-catenin and TCF4 (IC50 < 2 μM)
Pack SizePriceAvailabilityQuantity
2 mg28 €In Stock
5 mg45 €In Stock
10 mg70 €In Stock
25 mg142 €In Stock
50 mg249 €In Stock
100 mg377 €In Stock
1 mL x 10 mM (in DMSO)51 €In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "LF3"

Select Batch
Purity:≥95%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
LF3 is a specific inhibitor of canonical Wnt signaling by disrupting the interaction between β-catenin and TCF4 (IC50 < 2 μM)
Targets&IC50
β-catenin/TCF4 (ELISA):1.82 μM , β-catenin/TCF4 (Alpha Screen):1.65 μM
In vitro
LF3 inhibited Wnt/β-catenin signals in cells with exogenous reporters and in colon cancer cells with endogenously high Wnt activity. LF3 also suppressed features of cancer cells related to Wnt signaling, including high cell motility, cell-cycle progression, and the overexpression of Wnt target genes[1].
In vivo
LF3 reduced tumor growth and induced differentiation in a mouse xenograft model of colon cancer.LF3 is a specific inhibitor of canonical Wnt signaling with anticancer activity[1].
Animal Research
Unsorted GFPlow and GFPhigh SW480 cells (1 × 10^4) were subcutaneously injected into the back skin of NOD/SCID mice. Tumor growth was monitored over a period of 45 days. For therapy, LF3 was administered i.v. at 50 mg/kg body weight for three rounds over 5 consecutive days, with 2-day breaks[1].
Chemical Properties
Molecular Weight416.56
FormulaC20H24N4O2S2
Cas No.664969-54-4
SmilesNS(=O)(=O)c1ccc(NC(=S)N2CCN(C\C=C\c3ccccc3)CC2)cc1
Relative Density.1.341 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 32 mg/mL (76.82 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.4006 mL12.0031 mL24.0061 mL120.0307 mL
5 mM0.4801 mL2.4006 mL4.8012 mL24.0061 mL
10 mM0.2401 mL1.2003 mL2.4006 mL12.0031 mL
20 mM0.1200 mL0.6002 mL1.2003 mL6.0015 mL
50 mM0.0480 mL0.2401 mL0.4801 mL2.4006 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy LF3 | purchase LF3 | LF3 cost | order LF3 | LF3 chemical structure | LF3 in vivo | LF3 in vitro | LF3 formula | LF3 molecular weight